N/A
NPS Score
VS
MyoKardia Claimed Company
- EMPLOYEE
PARTICIPANTS - 2
- TOTAL
RATINGS
NGM Biopharmaceuticals Claimed Company
- EMPLOYEE
PARTICIPANTS - 10
- TOTAL
RATINGS
MyoKardia vs NGM Biopharmaceuticals
Competitors at MyoKardia is not yet available. Get insights into the competitive rankings of MyoKardia CEO Rating, Culture Score, Brand Ranking, and other rankings soon.
MyoKardia
MyoKardia's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of MyoKardia. Their current market cap is $11.99B.
NGM Biopharmaceuticals
NGM Biopharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of NGM Biopharmaceuticals. Their current market cap is $280.84M.
4/5
Product Quality
3.2/5
4/5
Pricing
4.1/5
4/5
Customer Service
5/5
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
20
NPS Score
| 60% | Promoters |
|---|---|
| 0% | Passive |
| 40% | Detractors |
Net Promoter Score
Winner by 20
See how MyoKardia compares to its competitors
See how NGM Biopharmaceuticals compares to its competitors
Working at MyoKardia vs Working at NGM Biopharmaceuticals
Not enough ratings
CEO Rating
86 / 100
CEO Rating
Winner
MyoKardia
MyoKardia doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
NGM Biopharmaceuticals
Employees at NGM Biopharmaceuticals rate their CEO, David Woodhouse, 86/100.